Miranda Kirby Selected Research

Biomarkers (Surrogate Marker)

4/2018	Development of a pulmonary imaging biomarker pipeline for phenotyping of chronic lung disease.
1/2018	Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
5/2017	Thoracic CT-MRI coregistration for regional pulmonary structure-function measurements of obstructive lung disease.
5/2017	MRI ventilation abnormalities predict quality-of-life and lung function changes in mild-to-moderate COPD: longitudinal TINCan study.
1/2017	Management of COPD: Is there a role for quantitative imaging?
9/2016	Three-dimensional ultrasound measurements of carotid vessel wall and plaque thickness and their relationship with pulmonary abnormalities in ex-smokers without airflow limitation.
5/2016	Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.
8/2013	Computed tomography biomarkers of pulmonary emphysema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miranda Kirby Research Topics

Disease

39	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 07/2010
9	Emphysema 12/2021 - 01/2012
8	Asthma (Bronchial Asthma) 11/2023 - 09/2013
5	Dyspnea (Shortness of Breath) 01/2024 - 08/2014
4	Lung Diseases (Lung Disease) 04/2018 - 09/2013
3	COVID-19 01/2023 - 01/2022
2	Infections 01/2023 - 11/2022
2	Obstructive Lung Diseases (Obstructive Lung Disease) 10/2020 - 08/2014
2	Pulmonary Emphysema 01/2018 - 08/2013
2	Disease Progression 10/2016 - 09/2014
2	Cystic Fibrosis (Mucoviscidosis) 09/2013 - 08/2011
1	Post-Acute COVID-19 Syndrome 11/2022
1	Lung Injury 12/2016
1	Airway Remodeling 04/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2013

Drug/Important Bio-Agent (IBA)

11	Carbon MonoxideIBA 12/2023 - 11/2012
11	GoldIBA 01/2022 - 08/2013
8	Biomarkers (Surrogate Marker)IBA 04/2018 - 08/2013
6	Bronchodilator Agents (Bronchodilators)IBA 01/2024 - 10/2011
6	Helium-3IBA 08/2013 - 07/2011
5	HeliumIBA 01/2020 - 07/2010
4	XenonIBA 01/2023 - 11/2012
3	SmokeIBA 11/2023 - 04/2016
3	Phenobarbital (Luminal)FDA Link 10/2022 - 01/2018
2	Clostridium perfringens epsilon-toxinIBA 01/2024 - 08/2014
2	prednylidene (Pred)IBA 05/2017 - 01/2016
2	Albuterol (Salbutamol)FDA LinkGeneric 08/2014 - 10/2011
2	HydrogenIBA 10/2011 - 07/2010
1	Oxygen (Dioxygen)IBA 01/2024
1	dupilumabIBA 11/2023
1	A-factor (Streptomyces)IBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2020
1	funiferine N-oxideIBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2016
1	Tobacco Smoke Pollution (Passive Smoking)IBA 08/2014
1	Methacholine Chloride (Methacholine)FDA Link 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	Xenon-129IBA 03/2013

Therapy/Procedure

5	Therapeutics 05/2017 - 10/2011
2	Lung Transplantation 01/2020 - 01/2018
1	Pneumonectomy (Lung Volume Reduction) 01/2018
1	Mechanical Ventilators (Ventilator) 12/2016
1	Bronchial Thermoplasty 09/2015
1	Stents 01/2012